Merck Drn Ed Mb (MRCK34)
BOV
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | 3.977 | 2.613 | 7.296 | 11.628 | 8.031 | 13.229 | 13.515 | 0.338 |
Return on Equity (%) | 9.215 | 6.394 | 20.244 | 36.726 | 27.495 | 40.995 | 34.44 | 0.872 |
Return on Invested Capital (%) | 15.649 | 7.848 | 23.725 | 31.705 | 23.091 | 30.977 | 29.015 | 4.303 |
Operating Margin (%) | 13.445 | 18.132 | 22.398 | 26.381 | 20.048 | 30.152 | 29.361 | 5.049 |
Net Profit Margin (%) | 9.848 | 5.967 | 14.707 | 20.732 | 14.725 | 26.792 | 24.491 | 0.607 |
Book Value Per Share | 1.742 | 0.772 | -1.07 | -2.972 | -2.62 | -2.327 | 1.273 | -0.615 |
Earnings Per Share | 1.411 | 0.88 | 2.376 | 3.787 | 1.962 | 5.112 | 4.031 | 0.143 |
Cash Per Share | 2.345 | 2.238 | 3.043 | 3.774 | 2.238 | 3.172 | 3.524 | 2.673 |
Working Capital Per Share | 4.826 | 2.26 | 1.402 | 2.053 | 0.121 | 2.505 | 3.188 | 2.53 |
Operating Profit Per Share | 11.426 | 11.787 | 12.64 | 14.189 | 10.483 | 15.001 | 12.71 | 18.703 |
EBIT Per Share | 1.677 | 2.396 | 3.324 | 4.471 | 2.441 | 5.437 | 4.565 | 0.738 |
EBITDA Per Share | 1.677 | 2.396 | 3.324 | 4.471 | 2.441 | 5.437 | 4.565 | 0.738 |
Free Cash Flow Per Share | 1.881 | 1.772 | 3.762 | 5.987 | 4.007 | 8.226 | 6.144 | 3.09 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 2.75B | 2.7B | 2.59B | 2.54B | 3.58B | 2.53B | 3.58B | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 3.58B | N/A | N/A | N/A | N/A | N/A | 2.53B | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 26.865 | N/A | N/A | N/A | 37.864 | N/A | N/A |
Net Profit Margin (%) | N/A | 19.473 | N/A | N/A | N/A | 30.187 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 2.23B |
Price to Earnings Ratio | 8.4 |
Price to Sales Ratio | 0.05 |
Price to Cash Ratio | 0.45 |
Price to Book Ratio | 0.08 |
Dividend Yield | 412.95% |
Shares Outstanding | 30.81M |
Average Volume (1 week) | 6.6k |
Average Volume (1 Month) | 5.84k |
52 Week Change | 15.06% |
52 Week High | 94.00 |
52 Week Low | 61.00 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.